↓ Skip to main content

Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter
17 X users
facebook
2 Facebook pages

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
220 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, March 2019
DOI 10.1002/14651858.cd012930.pub2
Pubmed ID
Authors

Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham, David JW Evans

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 220 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 32 15%
Student > Bachelor 22 10%
Researcher 19 9%
Other 15 7%
Student > Ph. D. Student 15 7%
Other 35 16%
Unknown 82 37%
Readers by discipline Count As %
Medicine and Dentistry 53 24%
Nursing and Health Professions 29 13%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Psychology 6 3%
Biochemistry, Genetics and Molecular Biology 6 3%
Other 22 10%
Unknown 92 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2019.
All research outputs
#3,721,203
of 25,461,852 outputs
Outputs from Cochrane database of systematic reviews
#6,352
of 12,090 outputs
Outputs of similar age
#79,487
of 366,390 outputs
Outputs of similar age from Cochrane database of systematic reviews
#113
of 150 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,390 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 150 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.